Pfizer Czech Republic - Indebtedness

Net Debt/EBITDA & Net Debt/Equity
Pharmaceutical | Czech Republic | March 19, 2018
$2.99
Excel Sheet

Pfizer Czech Republic's net debt reached CZK -284 mil and accounted for -0.168 of equity at the end of 2014. The ratio is down 977% when compared to the previous year.

Historically, the firm’s net debt to equity reached an all time high of 1.99 in 2006 and an all time low of -1.50 in 2004.

When compared to EBITDA, net debt amounted to -1.65x at the end of the year. The ratio reached an all time high of 5.38 in 2005 and an all time low of -1.65 in 2014.

As far as Pfizer Czech Republic's peers are concerned, Roche Czech Republic posted net debt to equity of 0.477x and 2.04x when compared to EBITDA at the end of 2014. Bayer Czech Republic ended the year 2014 with a net debt at 0.089x of equity and 0.150x when compared to its EBITDA while Bayer Czech Republic had net debt at 0.089x of equity and 0.150x to EBITDA at the end of the year.

You can see all the company’s data at Pfizer Czech Republic Profile, or you can download a report on the company in the report section.